PROCEPT BioRobotics Corpo... (PRCT)
PROCEPT BioRobotics Statistics
Share Statistics
PROCEPT BioRobotics has 54.82M shares outstanding. The number of shares has increased by 6.73% in one year.
| Shares Outstanding | 54.82M |
| Shares Change (YoY) | 6.73% |
| Shares Change (QoQ) | 4.74% |
| Owned by Institutions (%) | 96.76% |
| Shares Floating | 51.88M |
| Failed to Deliver (FTD) Shares | 4.33K |
| FTD / Avg. Volume | 0.47% |
Short Selling Information
The latest short interest is 7.07M, so 13% of the outstanding shares have been sold short.
| Short Interest | 7.07M |
| Short % of Shares Out | 13% |
| Short % of Float | 13.72% |
| Short Ratio (days to cover) | 11.83 |
Valuation Ratios
The PE ratio is -45.91 and the forward PE ratio is -57.05. PROCEPT BioRobotics's PEG ratio is 2.1.
| PE Ratio | -45.91 |
| Forward PE | -57.05 |
| PS Ratio | 18.7 |
| Forward PS | 4.8 |
| PB Ratio | 10.43 |
| P/FCF Ratio | -40.5 |
| PEG Ratio | 2.1 |
Enterprise Valuation
PROCEPT BioRobotics Corporation has an Enterprise Value (EV) of 1.8B.
| EV / Earnings | -19.72 |
| EV / Sales | 8.03 |
| EV / EBITDA | -21.98 |
| EV / EBIT | -18.66 |
| EV / FCF | -17.39 |
Financial Position
The company has a current ratio of 9.07, with a Debt / Equity ratio of 0.2.
| Current Ratio | 9.07 |
| Quick Ratio | 8.01 |
| Debt / Equity | 0.2 |
| Total Debt / Capitalization | 16.63 |
| Cash Flow / Debt | -1.24 |
| Interest Coverage | -23.09 |
Financial Efficiency
Return on equity (ROE) is -0.23% and return on capital (ROIC) is -20.02%.
| Return on Equity (ROE) | -0.23% |
| Return on Assets (ROA) | -0.17% |
| Return on Capital (ROIC) | -20.02% |
| Revenue Per Employee | $296,955.03 |
| Profits Per Employee | $-120,916.67 |
| Employee Count | 756 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 21.33% in the last 52 weeks. The beta is 1.05, so PROCEPT BioRobotics's price volatility has been higher than the market average.
| Beta | 1.05 |
| 52-Week Price Change | 21.33% |
| 50-Day Moving Average | 65.57 |
| 200-Day Moving Average | 74.26 |
| Relative Strength Index (RSI) | 45.32 |
| Average Volume (20 Days) | 917.72K |
Income Statement
In the last 12 months, PROCEPT BioRobotics had revenue of 224.5M and earned -91.41M in profits. Earnings per share was -1.75.
| Revenue | 224.5M |
| Gross Profit | 137.1M |
| Operating Income | -96.61M |
| Net Income | -91.41M |
| EBITDA | -82M |
| EBIT | -96.61M |
| Earnings Per Share (EPS) | -1.75 |
Balance Sheet
The company has 333.73M in cash and 80.25M in debt, giving a net cash position of 253.47M.
| Cash & Cash Equivalents | 333.73M |
| Total Debt | 80.25M |
| Net Cash | 253.47M |
| Retained Earnings | -545.99M |
| Total Assets | 534.02M |
| Working Capital | 428.71M |
Cash Flow
In the last 12 months, operating cash flow was -99.21M and capital expenditures -4.41M, giving a free cash flow of -103.62M.
| Operating Cash Flow | -99.21M |
| Capital Expenditures | -4.41M |
| Free Cash Flow | -103.62M |
| FCF Per Share | -1.99 |
Margins
Gross margin is 61.07%, with operating and profit margins of -43.04% and -40.72%.
| Gross Margin | 61.07% |
| Operating Margin | -43.04% |
| Pretax Margin | -40.72% |
| Profit Margin | -40.72% |
| EBITDA Margin | -36.52% |
| EBIT Margin | -43.04% |
| FCF Margin | -46.16% |
Dividends & Yields
PRCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.92% |
| FCF Yield | -3.15% |
Analyst Forecast
The average price target for PRCT is $95, which is 58.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $95 |
| Price Target Difference | 58.4% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Scores
| Altman Z-Score | 14.79 |
| Piotroski F-Score | 3 |